Compared with the control group, the expressions of TNF-α, IL-6, and IL-17 in PBMC of SLE patients were significantly increased, while the expression of IL-10 and TGF-β was dramatically reduced. The gene discussed is IL17A; the disease is systemic lupus erythematosus.